|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-10-10
|
|
pubmed:abstractText |
The aim of this study was to evaluate whether and to what extent fenofibrate (F), metformin (M) or a combination of these drugs improve characteristics of the metabolic syndrome (MetS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1462-8902
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
869-78
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17924869-Adolescent,
pubmed-meshheading:17924869-Adult,
pubmed-meshheading:17924869-Aged,
pubmed-meshheading:17924869-Blood Glucose,
pubmed-meshheading:17924869-Cholesterol, HDL,
pubmed-meshheading:17924869-Diabetes Mellitus, Type 2,
pubmed-meshheading:17924869-Dose-Response Relationship, Drug,
pubmed-meshheading:17924869-Drug Therapy, Combination,
pubmed-meshheading:17924869-Female,
pubmed-meshheading:17924869-Fenofibrate,
pubmed-meshheading:17924869-Humans,
pubmed-meshheading:17924869-Hypoglycemic Agents,
pubmed-meshheading:17924869-Hypolipidemic Agents,
pubmed-meshheading:17924869-Male,
pubmed-meshheading:17924869-Metabolic Syndrome X,
pubmed-meshheading:17924869-Metformin,
pubmed-meshheading:17924869-Middle Aged,
pubmed-meshheading:17924869-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
|
|
pubmed:affiliation |
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
